The FBRI is charged with general coordinating functions to promote and facilitate collaboration and integration among industrial, governmental, academic, and medical sectors; to support R&D leading to advances in healthcare and their clinical application; and to work toward the construction of next-generation healthcare systems. Through these activities, the FBRI expects to contribute to the creation of innovative healthcare technologies and the formation and accumulation of healthcare-related industries in Kobe. The FBRI’s ultimate goals are to revitalize Kobe’s economy, enhance local residents’ wellbeing, and contribute to the international community.
- ABOUT KBIC (KOBE Biomedical Innovation Cluster)
- On January 17, 1995, the Great Hanshin-Awaji Earthquake struck Kobe. Severely damaged and realizing anew the preciousness of life, Kobe pledged to not simply reconstruct itself in economic terms but to do so by becoming a place where life is cherished above all. The city thus launched the project to develop a prime hub of healthcare research and related services.
Visit KBIC website and read more.
- Development of the Kobe Biomedical Innovation Cluster (KBIC) through planning, human resource development, organization of academic meetings, information dissemination, facilitation of collaboration and integration among the industrial, governmental, academic and medical sectors, international exchange, etc.
- Innovation through the facilitation of collaboration among research institutions, universities, healthcare organizations, healthcare-related businesses, and other parties
- International development of KBIC
- Improvement of the research and operational environments within KBIC
- Research and development in the domain of regenerative medicine and cell therapy
- Research and development in the domain of medical devices
- Research and development in the domain of pharmaceutical drugs
- Research and development toward the realization of preemptive medicine
Focal areas in Above 2-5
- Identification of new healthcare “seeds,” mainly in the research areas of immunotherapy, brain and neurodegenerative disease, regenerative medicine, hematology– oncology and infectious disease.
- General support for R&D and clinical application
- Support for healthcare development relating to new domestic and international healthcare seeds, and notably the FBRI’s R&D seeds
- Upgrading of regenerative medicine in Kobe to the world’s highest standards through the development of next-generation cell culture systems and other initiatives
- Promotion of clinical application through collaboration with highly specialized healthcare organizations and other parties
- Support in various forms for new business creation and sophistication of existing businesses
- Licensing-out and practical application of development seeds in an integrated support system, realization of business projects
- Support for local residents’ health maintenance
- Management and operation of facilities related to the promotion of KBIC
- Other activities necessary for the promotion of KBIC
FBRI carries out the activities listed mainly at four centers: the Institute of Biomedical Research and Innovation (IBRI), the Translational Research Center for Medical Innovation (TRI), the Research and Development Center for Cell Therapy (RDC), and the Center for Cluster Development and Coordination (CCD).
Function of each center
Aiming to create new “seeds” of healthcare for a healthier and longer-lived society, the IBRI carries out fundamental research mainly in the research areas of immunotherapy, brain and neurodegenerative disease, regenerative medicine, hematology– oncology and infectious diseaseLink to the IBRI home page
Promotes translational research to develop new domestic and international “product candidates” into highly outstanding pharmaceutical drugs, regenerative medical products, medical devices, and so forth, working toward their pharmaceutical approval and earlier practical application.
Supports the development of cell therapy “seeds” through research on therapeutic stem cells and the manufacture of therapeutic cells, and works toward the upgrading of KBIC’s regenerative medicine to the world’s highest standards through the construction of next-generation cell culture systems and other initiatives.
Link to the RDC home page
Facilitates collaboration and integration among companies, universities, research centers, medical institutions and other establishments that constitute KBIC to realize synergetic effects from their concentration, constructs and maintains a seamless support system, and promotes KBIC’s international activities.
Link to the CCD home page
The IBRI hospital was closed on October 31, 2017.
If you need contact us 078-306-1700（ weekdays 9:00am-5:00pm ）